Yajun Wu - Humanwell Healthcare CFO VP
| 600079 Stock | 22.22 0.31 1.38% |
CFO
Yajun Wu is CFO VP of Humanwell Healthcare Group
| Age | 53 |
| Address | No. 666, Gaoxin Avenue, Wuhan, China, 430075 |
| Phone | 86 27 8759 7232 |
| Web | https://www.humanwell.com.cn |
Humanwell Healthcare Management Efficiency
The company has return on total asset (ROA) of 0.0601 % which means that it generated a profit of $0.0601 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1299 %, meaning that it generated $0.1299 on every $100 dollars invested by stockholders. Humanwell Healthcare's management efficiency ratios could be used to measure how well Humanwell Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. At present, Humanwell Healthcare's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 2.6 B, whereas Other Current Assets are forecasted to decline to about 173 M.Similar Executives
| Found 7 records | CFO Age | ||
| Donghua Shou | China Petroleum Chemical | 54 | |
| Huang Jie | China State Construction | 55 | |
| Hongbiao Zhu | China Railway Construction | 54 | |
| Cui Sun | China Railway Group | 58 | |
| Yunlin Wang | China State Construction | 59 | |
| Hua Wang | PetroChina Co Ltd | 49 | |
| Xiuming Wang | China Railway Construction | 61 | |
Management Performance
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0601 |
Humanwell Healthcare Leadership Team
Elected by the shareholders, the Humanwell Healthcare's board of directors comprises two types of representatives: Humanwell Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Humanwell. The board's role is to monitor Humanwell Healthcare's management team and ensure that shareholders' interests are well served. Humanwell Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Humanwell Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Qianlun Li, VP Secretary | ||
| Lie Li, Vice President | ||
| Qianlun JD, VP Secretary | ||
| Xiafei Deng, President Director | ||
| Yajun Wu, CFO VP | ||
| Qun Yu, Vice President | ||
| Hongjie Zhang, Vice President | ||
| Wentao Du, Vice President | ||
| Qiang Yin, Vice President |
Humanwell Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Humanwell Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0601 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 41.01 B | ||||
| Shares Outstanding | 1.63 B | ||||
| Shares Owned By Insiders | 36.50 % | ||||
| Shares Owned By Institutions | 20.77 % | ||||
| Price To Book | 2.03 X | ||||
| Price To Sales | 1.44 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Humanwell Stock
Humanwell Healthcare financial ratios help investors to determine whether Humanwell Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Humanwell with respect to the benefits of owning Humanwell Healthcare security.